Masooma Shifa Rana

9PUBLICATIONS
93CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Counselling psychology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 23, 2026
Impact of extramedullary plasmacytoma on outcomes in patients with relapsed refractory multiple myeloma treated with talquetamab: U.S. Myeloma Immunotherapy Consortium.

|Jul 11, 2026
Cancer history and second cancer risk in polycythemia vera and essential thrombocythemia.

|Jul 02, 2026
Real-world outcomes with BCMA- and GPRC5D-targeting bispecific antibodies in plasma cell leukemia.

|Apr 04, 2026
Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy.

Masooma Shifa Rana, Sebastian Fernandez-Pol, Alexandria Jensen

|Mar 19, 2026
Early steroid and anakinra use to manage axicabtagene ciloleucel toxicity reduces the total duration of CRS and ICANS.

William Lee Wang, Dasom Lee, Edna Cheung

|Nov 28, 2025
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience.

Aimaz Afrough, Danai Dima, Beatrice Razzo

Pageof 2

Frequent Collaborators

6 joint publications

Surbhi Sidana

4 joint publications

Jack Khouri

4 joint publications

Krina K Patel

4 joint publications

Kelley Julian